Inki Kim Selected Research

Inki Kim Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 01/2011
7	Breast Neoplasms (Breast Cancer) 11/2018 - 01/2012
4	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 11/2016
3	Lung Neoplasms (Lung Cancer) 01/2024 - 11/2012
3	Leukemia 09/2023 - 01/2014
2	Carcinoma (Carcinomatosis) 11/2020 - 11/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2017 - 01/2014
2	Brain Injuries (Brain Injury) 01/2015 - 01/2012
2	Hypoxia (Hypoxemia) 01/2015 - 12/2008
2	Necrosis 01/2013 - 11/2012
1	2 X-Linked Lymphoproliferative Syndrome 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023
1	Atherosclerosis 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Atherosclerotic Plaque (Atheroma) 12/2022
1	Myocardial Infarction 12/2022
1	Crohn Disease (Crohn's Disease) 08/2021
1	Hyperpigmentation 11/2019
1	Hematologic Neoplasms (Hematological Malignancy) 02/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2018
1	Adenocarcinoma 01/2018
1	Rheumatoid Arthritis 01/2018
1	Osteoarthritis 10/2017
1	Arthritis (Polyarthritis) 10/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2016
1	Glioma (Gliomas) 02/2016
1	Body Weight (Weight, Body) 03/2015
1	Alzheimer Disease (Alzheimer's Disease) 02/2015
1	Amyloid Plaque 02/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2014

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2008
6	LigandsIBA 07/2019 - 01/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2019 - 01/2014
3	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2024 - 07/2014
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2020
3	Histone MethyltransferasesIBA 12/2020 - 11/2018
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2020 - 01/2013
3	BIX 01294IBA 11/2020 - 11/2018
3	CaspasesIBA 01/2013 - 01/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2023 - 12/2022
2	Transcription Factor CHOPIBA 12/2020 - 11/2018
2	EuchromatinIBA 07/2019 - 11/2018
2	SurvivinIBA 07/2019 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 03/2015 - 01/2014
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2015 - 11/2013
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	SERPIN-B5 (maspin)IBA 12/2023
1	CyclinsIBA 09/2023
1	fms-Like Tyrosine Kinase 3IBA 09/2023
1	venetoclaxIBA 09/2023
1	p38 Mitogen-Activated Protein KinasesIBA 12/2022
1	AdipokinesIBA 12/2022
1	Apolipoproteins E (ApoE)IBA 12/2022
1	ML324IBA 02/2022
1	Histone DemethylasesIBA 02/2022
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Melanins (Melanin)IBA 11/2019
1	TransferasesIBA 07/2019
1	AzaguanineIBA 02/2019
1	Activating Transcription Factor 4IBA 11/2018
1	Histone-Lysine N-MethyltransferaseIBA 11/2018
1	Thioguanine (Tioguanine)FDA Link 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 12/2017
1	CytokinesIBA 10/2017
1	Inhibitor of Apoptosis ProteinsIBA 09/2017
1	7-benzylidenenaltrexoneIBA 09/2017
1	maleic acid (maleate)IBA 09/2017
1	Immunomodulating AgentsIBA 06/2017
1	Riluzole FDA LinkGeneric 11/2016
1	Glutamic Acid (Glutamate)FDA Link 11/2016
1	gambogic acidIBA 02/2016
1	xanthoneIBA 02/2016
1	CreatinineIBA 03/2015
1	Urea (Carbamide)FDA LinkGeneric 03/2015
1	NitrogenIBA 03/2015
1	Amyloid (Amyloid Fibrils)IBA 02/2015
1	Fibrinolysin FDA Link 02/2015
1	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2015
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2015
1	Plasminogen Activator Inhibitor 1IBA 02/2015
1	2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamideIBA 01/2015
1	Sodium AzideIBA 01/2015
1	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 01/2015
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2015
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2015
1	ZincIBA 01/2015
1	Ribosomal Proteins (Ribosomal Protein)IBA 07/2014
1	N(2)- (2- aminocyclohexyl)- N(6)- (3- chlorophenyl)- 9- ethyl- 9H- purine- 2,6- diamineIBA 07/2014
1	dacomitinibIBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014

Therapy/Procedure

9	Therapeutics 01/2024 - 11/2013
2	Radiotherapy 12/2023 - 03/2015
2	Immunotherapy 01/2020 - 06/2017
1	Stem Cell Transplantation 08/2021
1	Treatment Delay 01/2014